Hitomi Munakata

发表

Discovery of Apararenone (MT-3995) as a Highly Selective, Potent, and Novel Nonsteroidal Mineralocorticoid Receptor Antagonist.

K. Takedomi, Y. Yamamoto, K. Kikkawa, 2022, Journal of medicinal chemistry.